Replies to post #144516 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

RK on one hand you say
"When the study planned to do final analysis based on the trial statistical assumptions and when the injection treatments were scheduled to end are two different thing"

and the other you say
"it is my opinion that they will choose to take the study to the very end before doing the statistical analysis."

I have not heard any reason why they want all over sudden to go beyond the much communicated 233 OS endpoints. Again FDA agreed endpoints and consent for 36 months (by UCLA as Flipper pointed out) are two different things.

Having said that as anyone on this board. Yesterdays 10Q did not enlighten us in any way when data is or will be locked. Hence the unfortunate SP crash today.

[sentiment_stocks]

You know, you can always consider reconsidering your point. I do it all the time.

I don't even have to post half the old protocol to do it.